User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
PERF®-CNS Bridge Grant Program
The Pediatric Epilepsy Research Foundation® (PERF®) in partnership with the Child Neurology Society (CNS) offer the PERF®-CNS Bridge Grant Program to retain child neurology researchers. This program is designed to provide bridge funding to promising child neurology researchers who are applying for their first independent National Institutes of Health (NIH) or Canadian Institutes of Health Research (CIHR) research support. Through this grant mechanism, PERF® and CNS aim to assist investigators who have applied for their first NIH R01 or CIHR Operating/Project Grant support but were not funded.
This award is intended to retain investigators in child neurology clinical, translational, or basic research while they re-apply for NIH or CIHR funding.
Specialties
Eligibility Requirements
The following individuals are eligible to apply for this grant.
- Active members of the Child Neurology Society or membership application is in process.
- Have submitted their first NIH R01 or CIHR Operating/Project proposal during the past two years, and that grant was triaged or evaluated in the peer-review process but fell below (or is likely to fall below) the NIH or CIHR pay line.
- Investigators with K-Award (or equivalent) funding that will expire prior to the potential funding of their first R01 grant are eligible to apply, but current K-level funding is not a prerequisite.
- Investigators whose only federally funded grant is an R03 or R21 (or equivalent) award, and who are now re-submitting their first R01 or Operating/Project Grant, are eligible.
Eligible Countries:
Sponsor Details
Sponsor Institute/Organizations: Pediatric Epilepsy Research Foundation®
Sponsor Type:
Address: Pediatric Epilepsy Research Foundation® 8390 Lyndon B. Johnson Fwy, Suite 350 Dallas, TX 75243-1188
Legal & Affiliation Disclaimer
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Grant
Letter Of Intent Deadline:
Apr 14, 2025
Final Deadline:
Apr 14, 2025
Funding Amount:
$50,000
The Bridge Grant will be in the amount of $50,000 and will require a 1:1 match from the investigator’s (Awardee’s) Division or Department (thereby making $100,000 available to the Awardee).
Host Details
Affiliation: Pediatric Epilepsy Research Foundation®
Address: Pediatric Epilepsy Research Foundation® 8390 Lyndon B. Johnson Fwy, Suite 350 Dallas, TX 75243-1188
Website URL: https://www.pediatricepilepsyresearchfoundation.org/grants/our-current-grants/#registry
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts